We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Synchrony (SYF) & AGD Extend Partnership With 20-Year Deal
Read MoreHide Full Article
Synchrony Financial (SYF - Free Report) and The Academy of General Dentistry (“AGD”) announced the extension of their 20-year agreement, making CareCredit, an exclusive patient financing solution offered in AGD’s benefits program.
With SYF collaborating with AGD, it is evident that the company is focused on expanding the business with attention paid to health systems. Health and Wellness accounted for 16% of the total revenue of SYF in 2022. This collaboration will lead to increased contributions from this segment and a rise in the loan receivables portfolio, paving the way for higher interest income and fees on loans.
SYF’s collaboration with AGD highlights special financing options like value-added resources and digital payment features that CareCredit will provide to AGD’s members, comprising 35000 dentists.
Synchrony aims to provide dental patients access to treatments in a hassle-free way and provide dentists with educational resources, enabling them to deliver the best clinical care available. Patients can benefit from CareCredit when their medical insurance does not cover their full costs or to avail of special financing options that may not be available in other cards.
However, dental patients can check if they prequalify for the credit card and fill up the application. Once approved, patients are expected to utilize the credit card to pay dentists. There are short- and long-term financing options, providing flexibility to the user.
Synchrony provides financing solutions to its customers. It works with a diverse group of retailers, manufacturers, buying groups, merchants, industry associations and healthcare service providers, referred to as “partners”. Synchrony connects to its partners and customers through a dynamic financial ecosystem.
Price Performance
Shares of Synchrony have gained 5.4% year to date compared with the industry’s growth of 11.5%.
The bottom line of Euronet Worldwide outpaced estimates in three of the trailing four quarters, while it missed in one, the average surprise being 7.1%.
The Zacks Consensus Estimate for EEFT’s 2023 earnings suggests an improvement of 14.8% from the year-ago reported figure, while the same for revenues indicates growth of 9.2% . The consensus mark for EEFT’s 2023 earnings has moved 0.3% north in the past seven days.
Axos Financial’s bottom line outpaced estimates in each of the trailing four quarters. The average of earnings surprises is 8.1%.
The Zacks Consensus Estimate for AX’s 2023 earnings indicates a 15.1% rise from the prior-year reported figure, while the same for revenues suggests 22.6% growth.
The bottom line of StoneX Group outpaced the Zacks Consensus Estimatein each of the trailing four quarters, the average surprise being 45%. The consensus mark for SNEX’s 2023 earnings has moved 16.6% north in the past 30 days.
The Zacks Consensus Estimate for SNEX’s 2023 earnings indicates a 5.7% rise from the prior-year reported figure, while the same for revenues suggests 32.7% growth.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Synchrony (SYF) & AGD Extend Partnership With 20-Year Deal
Synchrony Financial (SYF - Free Report) and The Academy of General Dentistry (“AGD”) announced the extension of their 20-year agreement, making CareCredit, an exclusive patient financing solution offered in AGD’s benefits program.
With SYF collaborating with AGD, it is evident that the company is focused on expanding the business with attention paid to health systems. Health and Wellness accounted for 16% of the total revenue of SYF in 2022. This collaboration will lead to increased contributions from this segment and a rise in the loan receivables portfolio, paving the way for higher interest income and fees on loans.
SYF’s collaboration with AGD highlights special financing options like value-added resources and digital payment features that CareCredit will provide to AGD’s members, comprising 35000 dentists.
Synchrony aims to provide dental patients access to treatments in a hassle-free way and provide dentists with educational resources, enabling them to deliver the best clinical care available. Patients can benefit from CareCredit when their medical insurance does not cover their full costs or to avail of special financing options that may not be available in other cards.
However, dental patients can check if they prequalify for the credit card and fill up the application. Once approved, patients are expected to utilize the credit card to pay dentists. There are short- and long-term financing options, providing flexibility to the user.
Synchrony provides financing solutions to its customers. It works with a diverse group of retailers, manufacturers, buying groups, merchants, industry associations and healthcare service providers, referred to as “partners”. Synchrony connects to its partners and customers through a dynamic financial ecosystem.
Price Performance
Shares of Synchrony have gained 5.4% year to date compared with the industry’s growth of 11.5%.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Synchrony currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the same space are Euronet Worldwide (EEFT - Free Report) , Axos Financial (AX - Free Report) and StoneX Group (SNEX - Free Report) . All these companies carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The bottom line of Euronet Worldwide outpaced estimates in three of the trailing four quarters, while it missed in one, the average surprise being 7.1%.
The Zacks Consensus Estimate for EEFT’s 2023 earnings suggests an improvement of 14.8% from the year-ago reported figure, while the same for revenues indicates growth of 9.2% . The consensus mark for EEFT’s 2023 earnings has moved 0.3% north in the past seven days.
Axos Financial’s bottom line outpaced estimates in each of the trailing four quarters. The average of earnings surprises is 8.1%.
The Zacks Consensus Estimate for AX’s 2023 earnings indicates a 15.1% rise from the prior-year reported figure, while the same for revenues suggests 22.6% growth.
The bottom line of StoneX Group outpaced the Zacks Consensus Estimatein each of the trailing four quarters, the average surprise being 45%. The consensus mark for SNEX’s 2023 earnings has moved 16.6% north in the past 30 days.
The Zacks Consensus Estimate for SNEX’s 2023 earnings indicates a 5.7% rise from the prior-year reported figure, while the same for revenues suggests 32.7% growth.